Court cuts Boston Scientific patent penalty
In May, a Texas jury ruled that several Boston Scientific devices used to clear and prop open arteries infringed three Medtronic patents.
Boston Scientific stated Friday a U.S. District Court in Marshall, Texas, ruled that two of those patents are invalid and reduced Medtronic's award to $19 million.
Natick, Mass.-based Boston Scientific said it planned to appeal the $19 million decision to the U.S. Court of Appeals for the Federal Circuit.
On the New York Stock Exchange, shares of Medtronic Inc. fell 49 cents Friday to $54.72 while shares of Boston Scientific Corp. fell 18 cents to $12. (AP)